Serious myeloproliferative reactions associated with the use of thalidomide in myelofibrosis with myeloid metaplasia

被引:45
作者
Tefferi, A [1 ]
Elliott, MA [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Div Hematol & Internal Med, Rochester, MN 55905 USA
关键词
D O I
10.1182/blood.V96.12.4007.h8004000g_4007_4007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:4007 / 4007
页数:1
相关论文
共 3 条
[1]   THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS [J].
DAMATO, RJ ;
LOUGHNAN, MS ;
FLYNN, E ;
FOLKMAN, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :4082-4085
[2]  
Mesa RA, 2000, BLOOD, V96, P3374
[3]   Medical progress: Myelofibrosis with myeloid metaplasia. [J].
Tefferi, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (17) :1255-1265